HUM · Humana Inc · Executive Compensation
$411.79
-5.63 (-1.35%)
At close · Nov 5
Return incl. dividend (before tax)
Earnings today
Play latest call
Q2 2026 earnings call transcript
Market Cap
$50.12B
Shares
120.06M
Volume · Nov 5
1.36M
Avg daily vol (3M)
1.25M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| David E. Dintenfass | President, Enterprise Growth | $18,061,557 |
| James A. Rechtin | Chief Executive Officer | $15,579,476 |
| James Rechtin | CEO | $15,579,476 |
| Bruce D. Broussard | Former Chief Executive Officer | $12,057,164 |
| Susan M. Diamond | Chief Financial Officer | $9,617,514 |
| Susan Diamond | Chief Financial Officer | $9,617,514 |
| Sanjay Shetty | President, CenterWell | $6,435,263 |
| George Renaudin II | President, Insurance | $6,152,081 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Bruce D. Broussard | Former Chief Executive Officer | $16,327,384 |
| Susan M. Diamond | Chief Financial Officer | $4,730,733 |
| Susan Diamond | Chief Financial Officer | $4,730,733 |
| Sanjay Shetty | President, CenterWell | $4,581,941 |
| Joseph C. Ventura | Chief Legal Officer | $3,102,161 |
| George Renaudin II | President, Insurance | $3,052,478 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Bruce D. Broussard | Former Chief Executive Officer | $17,198,844 |
| Susan Diamond | Chief Financial Officer | $4,810,998 |
| Susan M. Diamond | Chief Financial Officer | $4,810,998 |
| T. Alan Wheatley | Segment President, Retail | $4,472,138 |
| Timothy S. Huval | Chief Administrative Officer | $3,734,570 |
| Joseph C. Ventura | Chief Legal Officer | $3,598,797 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Bruce D. Broussard | Chief Executive Officer | $16,528,036 |
| Brian A. Kane | FormerChief Financial Officer | $5,562,172 |
| T. Alan Wheatley | Segment President, Retail | $4,222,224 |
| Susan M. Diamond | Chief Financial Officer | $4,061,481 |
| Susan Diamond | Chief Financial Officer | $4,061,481 |
| Timothy S. Huval | Chief Administrative Officer | $3,502,023 |
| William K. Fleming | PharmD SegmentPresident , Pharmacy Solutions &Chief Corporate AffairsOfficer | $3,207,357 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Bruce D. Broussard | President and Chief Executive Officer | $16,489,639 |
| Brian A. Kane | FormerChief Financial Officer | $5,543,558 |
| T. Alan Wheatley | Segment President, Retail | $4,080,206 |
| Timothy S. Huval | Chief Administrative Officer | $3,472,435 |
| William K. Fleming | PharmD SegmentPresident , Pharmacy Solutions &Chief Corporate AffairsOfficer | $3,314,065 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Bruce D. Broussard | President and Chief Executive Officer | $16,726,455 |
| Brian A. Kane | FormerChief Financial Officer | $5,381,124 |
| T. Alan Wheatley | Segment President,Retail | $3,841,589 |
| Timothy S. Huval | ChiefAdministrative Officer | $3,510,125 |
| William K. Fleming | PharmD SegmentPresident , Pharmacy Solutions &Chief Corporate AffairsOfficer | $3,495,998 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Bruce D. Broussard | President and Chief Executive Officer | $16,312,517 |
| Brian A. Kane | Chief FinancialOfficer | $5,005,025 |
| Timothy S. Huval | Chief AdministrativeOfficer | $3,313,436 |
| William K. Fleming | PharmD Segment President, Clinical and Pharmacy Solutions | $3,156,678 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Bruce D. Broussard | President and ChiefExecutive Officer | $19,768,525 |
| Brian A. Kane | Chief Financial Officer | $5,658,476 |
| Timothy S. Huval | Chief Administrative Officer | $4,739,797 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Paul J. Smith | director | Appointed | 2026-07-29 |
| Frederick J. Crawford | director | Appointed | 2026-07-29 |
| Robert S. Field | director | Appointed | 2026-04-10 |
| Aaron Martin | President of Medicare Advantage | Appointed | 2025-12-16 |
| Celeste Mellet | Chief Financial Officer | Appointed | 2024-12-03 |
| Gordon Smith | director | Appointed | 2024-10-23 |
| James A. Rechtin | Board of Directors | Appointed | 2024-05-13 |
| Bruce D. Broussard | Board of Directors | Resigned | 2024-05-13 |
| James A. Rechtin | President and Chief Executive Officer | Appointed | 2024-05-13 |
| James A. Rechtin | President and Chief Operating Officer | Appointed | 2023-10-11 |
| Brad D. Smith | director of the Company | Appointed | 2022-09-15 |
Leadership
- Bruce D. Broussard CEO
- James A. Rechtin CEO, COO, Board Member
- Kurt J. Hilzinger Chairman
- Brian A. Kane CFO
- Susan M. Diamond CFO
- John-Paul W. Felter Chief Accounting Officer
- Michael A. Koeberlein Chief Accounting Officer
- David T. Feinberg Board Member
- David T. Feinberg, M.D. Board Member
- Frank A. D’Amelio Board Member
- Frederick J. Crawford Board Member
- Gordon Smith Board Member
- James Rechtin Board Member
- Jorge S. Mesquita Board Member
- Karen W. Katz Board Member
- Marcy S. Klevorn Board Member
- Paul J. Smith Board Member
- Raquel C. Bono Board Member
- Raquel C. Bono, M.D. Board Member
- Robert S. Field Board Member
- Wayne A.I. Frederick Board Member
Key facts
CIK
49071
CUSIP
444859102
13F (30d)
433 filings
394 filers
Visit website
Investor relations